endpoint Clinical | Patient Randomization & Clinical Supply Management
Redefine your RTSM!
Planning and optimizing complex clinical trials in oncology is challenging in an increasingly fast-paced environment. Knowing and understanding adaptive trial designs and master protocols such […]
Arena International are delighted to announce the return of Outsourcing in Clinical Trials Southern California this September for its 9th Annual event! Our 2022 programme boasts […]
Arena International are delighted to announce Outsourcing in Clinical Trials New England will be returning to Boston on the 12th-13th October 2022! Last year’s program included a […]
Drive Clinical Trial and Supply Chain Excellence Through Operational Best Practices and Interactive Response Technology Strategies Accelerate Successful Decentralized Trials, Clinical Supply Chain Optimization, Operational […]
We are excited to be hosting 20th Anniversary edition of Clinical Trial Supply East Coast on the 19th and 20th October 2022 in the Sheraton King of […]
This is the unmissable event that the pharmaceutical, biotechnology, and medical device communities need to come together and discuss strategies for operational success in clinical […]
NECSO, the New England Clinical Supplies Organization meeting is a day long forum for folks to learn the latest clinical supplies information in order to increase their value […]
A Chat with Industry Experts in Quality and Data Management about how Data is Reshaping the Industry In today’s digital world, data is king, and […]
After three years of COVID disruption, we are pleased to announce that the Outsourcing Clinical Trials DACH event will be returning to Munich on 30th November […]
The event which provides a platform for trial sponsors and solution providers in Texas to refine their outsourcing strategy, is back for 2022! Arena […]
Now more than ever, the important work of this clinical research community requires collaboration and innovation. In its 14th year of fostering these goals, SCOPE […]
In recent years, there has been an increase in regulatory scrutiny from clinical trial governing agencies, with a particular focus on the validation of computer […]